Retatrutide expands this concept with triple-receptor activation, adding GIP to the GLP-1 and glucagon combination
By facilitating GIP function at its full metabolic capacity alongside GLP-1, this interaction could effectively harness the full potential of incretin effect to enhance insulinotropic physiology and maintain euglycemia
From a patient burden standpoint, people living with advanced CKD take a number of oral medications and may prefer a once-weekly injection to an additional daily oral medication
In summary, triple receptor agonists orchestrate a multidimensional regulation of liver inflammation and fibrosis by modulating cytokine profiles, inhibiting fibrogenic signaling, and improving metabolic derangements that contribute to hepatic injury
Metabolic changes that show up in bloodwork (better fasting glucose, improved A1c, lower triglycerides) take 6 to 8 weeks to register
(2016, March 14)